<--- Back to Details
First PageDocument Content
Medicine / Clinical medicine / Transfusion medicine / Glycoproteins / Hematology / Immunoglobulin therapy / Transfusion-related acute lung injury / Blood type / Human cytomegalovirus / Ganciclovir
Date: 2016-05-09 16:44:34
Medicine
Clinical medicine
Transfusion medicine
Glycoproteins
Hematology
Immunoglobulin therapy
Transfusion-related acute lung injury
Blood type
Human cytomegalovirus
Ganciclovir

Product Monograph Cytogam® CYTOMEGALOVIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN) Liquid Formulation, Solvent Detergent Treated

Add to Reading List

Source URL: labeling.cslbehring.ca

Download Document from Source Website

File Size: 55,26 KB

Share Document on Facebook

Similar Documents

Instructions to Authors The Annals of Blood (AOB; aob.amegroups.com) publishes invited articles and submitted papers on all aspects of transfusion medicine and hematology,

Instructions to Authors The Annals of Blood (AOB; aob.amegroups.com) publishes invited articles and submitted papers on all aspects of transfusion medicine and hematology,

DocID: 1tFVB - View Document

IgG Sensitized Red Blood Cells ALBAcyte ®

IgG Sensitized Red Blood Cells ALBAcyte ®

DocID: 1rsVh - View Document

Microsoft Word - ISBT_definitions_final_2011_TRALIcorrectionadopted2013_IHNlogo.doc

Microsoft Word - ISBT_definitions_final_2011_TRALIcorrectionadopted2013_IHNlogo.doc

DocID: 1rsUZ - View Document

Who can make an apheresis donation? To qualify, donors must meet all required blood donation standards, including: • Be at least 17 years old. Donors under the age  Making an apheresis donation is

Who can make an apheresis donation? To qualify, donors must meet all required blood donation standards, including: • Be at least 17 years old. Donors under the age Making an apheresis donation is

DocID: 1rrmk - View Document

International Society of Blood Transfusion Financial Statements 31 March 2013 Table of Contents Page

International Society of Blood Transfusion Financial Statements 31 March 2013 Table of Contents Page

DocID: 1rq9j - View Document